NDC 0074-7040 – Skyrizi
· Kit
Product NDC0074-7040
Product details
- Brand name
- Skyrizi
- Generic name
- Risankizumab-rzaa
- Labeler
- AbbVie Inc.
- Dosage form
- Kit
- Marketing category
- BLA · BLA761105
- Marketed since
- March 4, 2024
- Listing expires
- December 31, 2027
Active ingredients
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0074-7040-02 | 2 CARTON in 1 CARTON (0074-7040-02) / 1 KIT in 1 CARTON * 1 mL in 1 SYRINGE, GLASS (0074-7032-01) | Mar 4, 2024 |
Other Skyrizi products
- 0074-1065 · Kit · AbbVie Inc.
- 0074-1070 · Kit · AbbVie Inc.
- 0074-7042 · Kit · AbbVie Inc.
- 0074-1050 Risankizumab 150 mg/mL · Injection · AbbVie Inc.
- 0074-2100 Risankizumab 150 mg/mL · Injection · AbbVie Inc.
- 0074-4059 Risankizumab 55 mg/.37mL · Injection, Solution · AbbVie Inc.
- 0074-5015 Risankizumab 600 mg/10mL · Injection · AbbVie Inc.
- 0074-8300 Risankizumab 180 mg/1.2mL · Injection · AbbVie Inc.
- 0074-8350 Risankizumab 180 mg/1.2mL · Injection · AbbVie Inc.